Literature DB >> 15494612

Expression and activity of steroid aldoketoreductases 1C in omental adipose tissue are positive correlates of adiposity in women.

Karine Blouin1, Sophie Blanchette, Christian Richard, Pierre Dupont, Van Luu-The, André Tchernof.   

Abstract

We examined expression and activity of steroid aldoketoreductase (AKR) 1C enzymes in adipose tissue in women. AKR1C1 (20alpha-hydroxysteroid dehydrogenase; 20alpha-HSD), AKR1C2 (3alpha-HSD-3), and AKR1C3 (17beta-HSD-5) are involved mainly in conversion of progesterone to 20alpha-hydroxyprogesterone and inactivation of dihydrotestosterone to 5alpha-androstane-3alpha,17beta-diol. Abdominal subcutaneous and omental adipose tissue biopsies were obtained during abdominal hysterectomies in seven women with low visceral adipose tissue (VAT) area and seven age- and total body fat mass-matched women with visceral obesity. Women with elevated VAT areas were characterized by significantly higher omental adipose tissue 20alpha-HSD and 3alpha-HSD-3 mRNA abundance compared with women with low VAT accumulations (1.4- and 1.6-fold differences, respectively; P < 0.05). Omental and subcutaneous adipose tissue 3alpha-HSD activities were significantly higher in women with high vs. low VAT areas (P < 0.05 for both comparisons). Total and visceral adiposities were positively associated with omental 20alpha-HSD mRNA level (r = 0.75, P < 0.003 for fat mass; r = 0.57, P < 0.04 for VAT area) and omental 3alpha-HSD-3 mRNA level (r = 0.68, P < 0.01 for fat mass; r = 0.74, P < 0.003 for VAT area). Enzyme activities in both depots were also positively correlated with adiposity measures. Omental adipose tissue enzyme expression and activity were positively associated with omental adipocyte size and LPL activity. In conclusion, mRNA abundance and activity of AKR1C enzymes in abdominal adipose tissue compartments are positive correlates of adiposity in women. Increased progesterone and/or dihydrotestosterone reduction in abdominal adipose tissue may impact locally on fat cell metabolism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15494612     DOI: 10.1152/ajpendo.00312.2004

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  13 in total

1.  Androgens, body fat Distribution and Adipogenesis.

Authors:  Mouna Zerradi; Julie Dereumetz; Marie-Michèle Boulet; André Tchernof
Journal:  Curr Obes Rep       Date:  2014-12

2.  Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in males.

Authors:  Donna L White; Yanhong Liu; Jose Garcia; Hashem B El-Serag; Li Jiao; Spiridon Tsavachidis; Luis M Franco; Ju-Seog Lee; Shahriar Tavakoli-Tabasi; David Moore; Radoslav Goldman; Jill Kuzniarek; David J Ramsey; Fasiha Kanwal; Marco Marcelli
Journal:  Int J Mol Epidemiol Genet       Date:  2014-10-22

3.  Gender-specific genetic associations of polymorphisms in ACE, AKR1C2, FTO and MMP2 with weight gain over a 10-year period.

Authors:  Freek G Bouwman; Jolanda M A Boer; Sandra Imholz; Ping Wang; W M Monique Verschuren; Martijn E T Dollé; Edwin C M Mariman
Journal:  Genes Nutr       Date:  2014-10-17       Impact factor: 5.523

4.  Adipocytes Sequester and Metabolize the Chemotherapeutic Daunorubicin.

Authors:  Xia Sheng; Jean-Hugues Parmentier; Jonathan Tucci; Hua Pei; Omar Cortez-Toledo; Christina M Dieli-Conwright; Matthew J Oberley; Michael Neely; Etan Orgel; Stan G Louie; Steven D Mittelman
Journal:  Mol Cancer Res       Date:  2017-11-08       Impact factor: 5.852

5.  Large trans-ethnic meta-analysis identifies AKR1C4 as a novel gene associated with age at menarche.

Authors:  C Sarnowski; D L Cousminer; N Franceschini; L M Raffield; G Jia; L Fernández-Rhodes; S F A Grant; H Hakonarson; L A Lange; J Long; T Sofer; R Tao; R B Wallace; Q Wong; G Zirpoli; E Boerwinkle; J P Bradfield; A Correa; C L Kooperberg; K E North; J R Palmer; B S Zemel; W Zheng; J M Murabito; K L Lunetta
Journal:  Hum Reprod       Date:  2021-06-18       Impact factor: 6.918

6.  Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women.

Authors:  Alain Veilleux; Maude Caron-Jobin; Suzanne Noël; Philippe Y Laberge; André Tchernof
Journal:  Diabetes       Date:  2011-03-18       Impact factor: 9.461

7.  Characterization of the aldo-keto reductase 1C gene cluster on pig chromosome 10: possible associations with reproductive traits.

Authors:  Dan J Nonneman; Tommy H Wise; J Joe Ford; Larry A Kuehn; Gary A Rohrer
Journal:  BMC Vet Res       Date:  2006-09-13       Impact factor: 2.741

8.  AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome.

Authors:  Michael W O'Reilly; Punith Kempegowda; Mark Walsh; Angela E Taylor; Konstantinos N Manolopoulos; J William Allwood; Robert K Semple; Daniel Hebenstreit; Warwick B Dunn; Jeremy W Tomlinson; Wiebke Arlt
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

9.  11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome.

Authors:  Michael W O'Reilly; Punith Kempegowda; Carl Jenkinson; Angela E Taylor; Jonathan L Quanson; Karl-Heinz Storbeck; Wiebke Arlt
Journal:  J Clin Endocrinol Metab       Date:  2017-03-01       Impact factor: 5.958

Review 10.  Is adiposopathy (sick fat) an endocrine disease?

Authors:  H E Bays; J M González-Campoy; R R Henry; D A Bergman; A E Kitabchi; A B Schorr; H W Rodbard
Journal:  Int J Clin Pract       Date:  2008-08-04       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.